News
“DGX Cloud Lepton is connecting Europe’s developers to a global AI infrastructure,” said Jensen Huang, founder and CEO of NVIDIA. “With partners across the region, we’re building a network of AI ...
4d
News-Medical.Net on MSNPsilocybin rewires the brain for weeks, study findsPsilocybin induces consistent and sustained changes in brain network connectivity, particularly between the hippocampus and ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
2d
News-Medical.Net on MSNYellow pigment linked to protection against severe malariaNew research suggests that a pigment that causes yellowing of the skin, or jaundice, may help protect people from the most ...
Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NW Bio"), a biotechnology company developing DCVax® personalized ...
Multiple sclerosis is a long-term autoimmune disorder in which the immune system mistakenly attacks the protective sheath ...
BioNTech continued to grow its oncology business by agreeing to buy fellow German biotech CureVac for $1.25 billion in a deal that combines two of the world's leaders in mRNA treatments.
Read the latest analysis on Nuvation Bio stock. Solid financials, positive analyst sentiment, and insider buying support ...
Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small molecule drug targeting early-stage Alzheimer's disease (AD). TML-6 combines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results